4.7 Review

The signal pathways and treatment of cytokine storm in COVID-19

期刊

出版社

SPRINGERNATURE
DOI: 10.1038/s41392-021-00679-0

关键词

-

资金

  1. National Key RAMP
  2. D Program of China [2016YFC1305102]
  3. National Natural Science Foundation of China [81671561, 81974248]
  4. International Joint Laboratory Program of National Children's Medical Center [EK1125180109]
  5. Program for Outstanding Medical Academic Leader [2019LJ19]
  6. Shanghai Municipal Planning Commission of Science and Research Fund [201740065]
  7. Shanghai Committee of Science and Technology [21140902400, 21ZR1410000, 19ZR1406400]
  8. Versus Arthritis UK [21327]
  9. Shenzhen Science and Technology Peacock Team Project [KQTD20170331145453160]

向作者/读者索取更多资源

The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.
The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) response, antibody-dependent enhancement, and especially, cytokine storm (CS). The CS is characterized by hyperproduction of an array of pro-inflammatory cytokines and is closely associated with poor prognosis. These excessively secreted pro-inflammatory cytokines initiate different inflammatory signaling pathways via their receptors on immune and tissue cells, resulting in complicated medical symptoms including fever, capillary leak syndrome, disseminated intravascular coagulation, acute respiratory distress syndrome, and multiorgan failure, ultimately leading to death in the most severe cases. Therefore, it is clinically important to understand the initiation and signaling pathways of CS to develop more effective treatment strategies for COVID-19. Herein, we discuss the latest developments in the immunopathological characteristics of COVID-19 and focus on CS including the current research status of the different cytokines involved. We also discuss the induction, function, downstream signaling, and existing and potential interventions for targeting these cytokines or related signal pathways. We believe that a comprehensive understanding of CS in COVID-19 will help to develop better strategies to effectively control immunopathology in this disease and other infectious and inflammatory diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据